Literature DB >> 1006213

Causes of death in autopsied RA patients.

O Mutru, K Koota, H Isomäki.   

Abstract

Among 3115 autopsied patients, rheumatoid arthritis was registered in 41 patients (1.3%). The causes of death of these were correlated with the causes of death of 310 non-rheumatoid autopsied patients. Of the RA patients, 32% died from cardiovascular disease, 24% from infection, 27% from renal failure and 7% from malignant disease. Of the control patients, 42% died from cardiovascular disease, 9% from infection, 3% from renal failure, and 23% from malignant disease. The low frequency of malignant disease as a cause of death in RA patients may be due to a continuous immunological stimulation or due to a missed diagnosis of RA in patients who died from malignant disease.

Entities:  

Mesh:

Year:  1976        PMID: 1006213     DOI: 10.3109/03009747609099912

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  15 in total

1.  Inflammation-mediated rheumatic diseases and atherosclerosis.

Authors:  S Manzi; M C Wasko
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

2.  Programmed initiation of hemodialysis for systemic amyloidosis patients associated with rheumatoid arthritis.

Authors:  Takeshi Kuroda; Naohito Tanabe; Daisuke Kobayashi; Hiroe Sato; Yoko Wada; Shuichi Murakami; Minoru Sakatsume; Masaaki Nakano; Ichiei Narita
Journal:  Rheumatol Int       Date:  2010-03-28       Impact factor: 2.631

Review 3.  What happens to patients with rheumatoid arthritis? The long-term outcome of treatment.

Authors:  T D Spector; D L Scott
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

4.  The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up.

Authors:  J A Baltus; J W Boersma; A P Hartman; J P Vandenbroucke
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

5.  Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.

Authors: 
Journal:  Ann Rheum Dis       Date:  1982       Impact factor: 19.103

6.  Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients.

Authors:  P A Reilly; J A Cosh; P J Maddison; J J Rasker; A J Silman
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

7.  HLA typing and seropositivity in Finnish and in Polish patients with rheumatoid arthritis and amyloidosis.

Authors:  S Tiitinen; K Kaarela; A Filipowicz-Sosnowska; B Maczynska-Rusiniak; K Lehtinen; M Leirisalo-Repo; L Paimela; S Koskimies
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

8.  Renal findings in rheumatoid arthritis: clinical aspects of 132 necropsies.

Authors:  M Boers; A M Croonen; B A Dijkmans; F C Breedveld; F Eulderink; A Cats; J J Weening
Journal:  Ann Rheum Dis       Date:  1987-09       Impact factor: 19.103

9.  Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis.

Authors:  M Laakso; O Mutru; H Isomäki; K Koota
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

10.  Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine.

Authors:  P Lewis; B L Hazleman; R Hanka; S Roberts
Journal:  Ann Rheum Dis       Date:  1980-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.